PICIOTTI, ROBERTO

PICIOTTI, ROBERTO  

Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti  

Mostra records
Risultati 1 - 15 di 15 (tempo di esecuzione: 0.0 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
Programmed cell death 1 genetic variant and liver damage in nonalcoholic fatty liver disease 2023 Malvestiti, FrancescoDongiovanni, PaolaFracanzani, Anna LMeroni, MaricaPiciotti, RobertoValenti, Luca + Article (author) -
TM6SF2/PNPLA3/MBOAT7 Loss-of-Function Genetic Variants Impact on NAFLD Development and Progression Both in Patients and in In Vitro Models 2022 Miriam LongoMarica MeroniErika PaoliniFrancesco FortunatoDario RonchiRoberto PiciottiChiara MacchiGiacomo Pietro ComiLuca ValentiMassimiliano RuscicaAnna L. FracanzaniPaola Dongiovanni + Article (author) -
MAFLD definition underestimates the risk to develop HCC in genetically predisposed patients 2022 Meroni, MaricaLongo, MiriamPaolini, ErikaLombardi, RosaPiciotti, RobertoFrancione, PaoloBadiali, SaraFracanzani, Anna LudovicaDongiovanni, Paola + Article (author) -
Recreating gut-liver axis during NAFLD onset by using a Caco-2/HepG2 co-culture system 2022 M. MeroniE. PaoliniM. LongoR. PiciottiS. FargionA. Ludovica FracanzaniP. Dongiovanni + Article (author) -
{PD}-1/{PD}-L1 Immuno-Mediated Therapy in {NAFLD}: Advantages and Obstacles in the Treatment of Advanced Disease 2022 Rosa LombardiRoberto PiciottiPaola DongiovanniMarica MeroniSilvia FargionAnna Ludovica Fracanzani Article (author) -
How to Best Exploit Immunotherapeutics in Advanced Gastric Cancer : Between Biomarkers and Novel Cell-Based Approaches 2021 Trapani, DarioSajjadi, ElhamPiciotti, RobertoFusco, Nicola + Article (author) -
Immunotherapy in breast cancer patients: A focus on the use of the currently available biomarkers in oncology 2021 Criscitiello CGuerini-Rocco ESajjadi EVenetis KPiciotti RFusco N + Article (author) -
Understanding the biology of volumetric muscle loss for an individualized exercise rehabilitation approach in breast cancer patients 2021 Venetis K.Sajjadi E.Piciotti R.Fusco N. + Article (author) -
Mismatch repair-deficient hormone receptor-positive breast cancers : Biology and pathological characterization 2021 Sajjadi E.Venetis K.Piciotti R.Guerini-Rocco E.Fusco N. + Article (author) -
Combined analysis of PTEN, HER2, and hormone receptors status: remodeling breast cancer risk profiling 2021 Sajjadi E.Venetis K.Piciotti R.Gambini D.Blundo C.Ferrero S.Guerini-Rocco E.Fusco N. + Article (author) -
Breast Cancer with Bone Metastasis: Molecular Insights and Clinical Management 2021 Konstantinos VenetisRoberto PiciottiElham SajjadiStefania MorgantiCarmen CriscitielloNicola Fusco + Article (author) -
Early Breast Cancers During Pregnancy Treated With Breast-Conserving Surgery in the First Trimester of Gestation: A Feasibility Study 2021 Fusco, NicolaSajjadi, ElhamVenetis, KonstantinosPiciotti, RobertoGuerini-Rocco, ElenaViale, GiuseppeVeronesi, Paolo + Article (author) -
Assessment of estrogen receptor low positive status in breast cancer: Implications for pathologists and oncologists 2021 Fusco N.Sajjadi E.Venetis K.Piciotti R.Morganti S.Criscitiello C. + Article (author) -
Mismatch Repair Status Characterization in Oncologic Pathology : Taking Stock of the Real-World Possibilities 2021 Piciotti, RobertoVenetis, KonstantinosSajjadi, ElhamFusco, Nicola Article (author) -
MICAL2 is essential for myogenic lineage commitment. 2020 Giarratana NPiciotti RTorrente Y + Article (author) -